Bifonazole

Bifonazole: an antifungal agent for the treatment of dermatomycosis and onychomycosis

Bifonazole is an imidazole-triazole derivative antifungal agent that is used to treat a variety of skin fungal infections. The drug was developed in Russia and Spain, and is now produced by several companies, including Synthesis AKO and Chemo Iberica.

Dosage forms of Bifonazole include substance, 1% solution, 1% cream and 1% powder. The active substance is bifonazole. The product is used for the treatment of dermatomycosis, such as superficial candidiasis, dermatophytosis, pityriasis versicolor, erythrasma, as well as onychomycosis.

Contraindications for the use of Bifonazole include hypersensitivity to the drug. Restrictions for use include infancy. When using the drug, side effects may occur, such as mild redness or irritation of the skin, burning, tingling, contact dermatitis, on the nail bed (treatment of onychomycosis) - irritation, redness, maceration, peeling; allergic reactions.

The interaction of Bifonazole with other drugs has not been studied. There is no information about an overdose of the drug.

Special instructions when using Bifonazole include the use of other waterproof dressings or surgical finger guards if an allergic reaction to the patch occurs.

Thus, Bifonazole is an effective antifungal drug for the treatment of various skin fungal infections, including onychomycosis. However, before using the drug, you should consult your doctor and carefully study the instructions for use.